March 3, 2026Open Access

Genetically Shared Signatures Between COVID-19 and Cancer Identified Through In Silico Case–Control Analysis

Key Points

The analysis highlights immune activation as a common theme between severe COVID-19 and aggressive cancers, emphasizing potential molecular connections.
Severe COVID-19 cases show notable shared molecular features with specific types of cancer, indicating underlying immune communication changes.
This assessment is a severity-stratified analysis of COVID-19 cases versus aggressive cancer cases, providing insights into immune responses.
These findings may spur biomarker discovery and guide therapeutic strategies for cancer patients vulnerable to COVID-19.

Abstract

This integrative, severity-stratified analysis identifies shared molecular and regulatory features linking severe COVID-19 with aggressive cancers, highlighting persistent immune activation and altered immune communication as common underlying themes without implying causality or clinical outcome effects. These findings provide a systems-level, hypothesis-generating framework for understanding virus-cancer interactions and may inform future biomarker discovery and immune-focused therapeutic strategies in vulnerable cancer populations.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Aziz Ahmed

Sevinç Akçay

Journals

Genes

Actions

Institutions

Ahi Evran University

University of Al Maarif

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Genetically Shared Signatures Between COVID-19 and Cancer Identified Through In Silico Case–Control Analysis

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study